nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—polycystic ovary syndrome—ovarian cancer	0.535	1	CtDrD
Metformin—NDUFS2—Doxorubicin—ovarian cancer	0.0676	0.272	CbGbCtD
Metformin—NDUFS3—Doxorubicin—ovarian cancer	0.0676	0.272	CbGbCtD
Metformin—NDUFS7—Doxorubicin—ovarian cancer	0.0676	0.272	CbGbCtD
Metformin—SLC22A3—Melphalan—ovarian cancer	0.0456	0.183	CbGbCtD
Metformin—NDUFA2—Vincristine—Vinorelbine—ovarian cancer	0.0014	1	CbGdCrCtD
Metformin—NDUFB6—female reproductive system—ovarian cancer	0.000166	0.00192	CbGeAlD
Metformin—NDUFB2—bone marrow—ovarian cancer	0.000166	0.00191	CbGeAlD
Metformin—PRKAB1—decidua—ovarian cancer	0.000165	0.00191	CbGeAlD
Metformin—NDUFS1—female reproductive system—ovarian cancer	0.000165	0.0019	CbGeAlD
Metformin—NDUFC2—epithelium—ovarian cancer	0.000165	0.0019	CbGeAlD
Metformin—NDUFAF1—bone marrow—ovarian cancer	0.000164	0.0019	CbGeAlD
Metformin—NDUFB10—female reproductive system—ovarian cancer	0.000164	0.00189	CbGeAlD
Metformin—NDUFC2—uterine cervix—ovarian cancer	0.000163	0.00189	CbGeAlD
Metformin—ND6—bone marrow—ovarian cancer	0.000163	0.00188	CbGeAlD
Metformin—NDUFA10—female gonad—ovarian cancer	0.000162	0.00188	CbGeAlD
Metformin—NDUFB7—female reproductive system—ovarian cancer	0.000162	0.00188	CbGeAlD
Metformin—NDUFA12—female reproductive system—ovarian cancer	0.000162	0.00188	CbGeAlD
Metformin—NDUFB3—bone marrow—ovarian cancer	0.000162	0.00187	CbGeAlD
Metformin—NDUFAF2—bone marrow—ovarian cancer	0.000162	0.00187	CbGeAlD
Metformin—NDUFS8—female reproductive system—ovarian cancer	0.000161	0.00186	CbGeAlD
Metformin—NDUFC1—female gonad—ovarian cancer	0.000161	0.00186	CbGeAlD
Metformin—NDUFC1—vagina—ovarian cancer	0.00016	0.00185	CbGeAlD
Metformin—NDUFB2—female gonad—ovarian cancer	0.00016	0.00184	CbGeAlD
Metformin—ND2—testis—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—ND4L—testis—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—ND3—testis—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—ND5—testis—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—NDUFA6—female reproductive system—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—NDUFB5—female reproductive system—ovarian cancer	0.000159	0.00184	CbGeAlD
Metformin—NDUFB2—vagina—ovarian cancer	0.000159	0.00183	CbGeAlD
Metformin—NDUFAF1—female gonad—ovarian cancer	0.000158	0.00183	CbGeAlD
Metformin—NDUFS4—female reproductive system—ovarian cancer	0.000158	0.00183	CbGeAlD
Metformin—NDUFA7—lymph node—ovarian cancer	0.000158	0.00182	CbGeAlD
Metformin—NDUFA5—bone marrow—ovarian cancer	0.000158	0.00182	CbGeAlD
Metformin—NDUFAF1—vagina—ovarian cancer	0.000157	0.00182	CbGeAlD
Metformin—ND6—female gonad—ovarian cancer	0.000157	0.00181	CbGeAlD
Metformin—NDUFS2—uterine cervix—ovarian cancer	0.000157	0.00181	CbGeAlD
Metformin—NDUFAF4—bone marrow—ovarian cancer	0.000157	0.00181	CbGeAlD
Metformin—NDUFB6—bone marrow—ovarian cancer	0.000157	0.00181	CbGeAlD
Metformin—PRKAB1—endometrium—ovarian cancer	0.000157	0.00181	CbGeAlD
Metformin—NDUFB4—female reproductive system—ovarian cancer	0.000156	0.0018	CbGeAlD
Metformin—NDUFAF2—female gonad—ovarian cancer	0.000156	0.0018	CbGeAlD
Metformin—NDUFB3—female gonad—ovarian cancer	0.000156	0.0018	CbGeAlD
Metformin—NDUFS1—bone marrow—ovarian cancer	0.000156	0.0018	CbGeAlD
Metformin—NDUFC2—decidua—ovarian cancer	0.000155	0.0018	CbGeAlD
Metformin—NDUFAB1—female reproductive system—ovarian cancer	0.000155	0.00179	CbGeAlD
Metformin—NDUFS3—uterine cervix—ovarian cancer	0.000155	0.00179	CbGeAlD
Metformin—NDUFAF2—vagina—ovarian cancer	0.000155	0.00179	CbGeAlD
Metformin—NDUFB3—vagina—ovarian cancer	0.000155	0.00179	CbGeAlD
Metformin—NDUFB10—bone marrow—ovarian cancer	0.000154	0.00178	CbGeAlD
Metformin—ND4—testis—ovarian cancer	0.000154	0.00178	CbGeAlD
Metformin—NDUFB9—female reproductive system—ovarian cancer	0.000154	0.00178	CbGeAlD
Metformin—NDUFA8—female reproductive system—ovarian cancer	0.000154	0.00178	CbGeAlD
Metformin—NDUFB7—bone marrow—ovarian cancer	0.000153	0.00177	CbGeAlD
Metformin—NDUFA12—bone marrow—ovarian cancer	0.000153	0.00177	CbGeAlD
Metformin—NDUFA4—female reproductive system—ovarian cancer	0.000153	0.00177	CbGeAlD
Metformin—NDUFS8—bone marrow—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFB1—bone marrow—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFV1—female reproductive system—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFB11—female reproductive system—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFA5—female gonad—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFA11—female gonad—ovarian cancer	0.000152	0.00176	CbGeAlD
Metformin—NDUFB8—female reproductive system—ovarian cancer	0.000151	0.00175	CbGeAlD
Metformin—NDUFS5—female reproductive system—ovarian cancer	0.000151	0.00175	CbGeAlD
Metformin—NDUFA11—vagina—ovarian cancer	0.000151	0.00175	CbGeAlD
Metformin—NDUFA5—vagina—ovarian cancer	0.000151	0.00175	CbGeAlD
Metformin—NDUFA2—testis—ovarian cancer	0.000151	0.00175	CbGeAlD
Metformin—NDUFAF4—female gonad—ovarian cancer	0.000151	0.00174	CbGeAlD
Metformin—NDUFB6—female gonad—ovarian cancer	0.000151	0.00174	CbGeAlD
Metformin—NDUFB5—bone marrow—ovarian cancer	0.00015	0.00174	CbGeAlD
Metformin—NDUFA6—bone marrow—ovarian cancer	0.00015	0.00174	CbGeAlD
Metformin—NDUFAF4—vagina—ovarian cancer	0.00015	0.00173	CbGeAlD
Metformin—NDUFB6—vagina—ovarian cancer	0.00015	0.00173	CbGeAlD
Metformin—NDUFS1—female gonad—ovarian cancer	0.00015	0.00173	CbGeAlD
Metformin—NDUFS2—decidua—ovarian cancer	0.000149	0.00173	CbGeAlD
Metformin—NDUFS4—bone marrow—ovarian cancer	0.000149	0.00172	CbGeAlD
Metformin—NDUFB10—female gonad—ovarian cancer	0.000149	0.00172	CbGeAlD
Metformin—NDUFB10—vagina—ovarian cancer	0.000148	0.00171	CbGeAlD
Metformin—NDUFA12—female gonad—ovarian cancer	0.000148	0.00171	CbGeAlD
Metformin—NDUFB7—female gonad—ovarian cancer	0.000148	0.00171	CbGeAlD
Metformin—NDUFS3—decidua—ovarian cancer	0.000148	0.00171	CbGeAlD
Metformin—NDUFC2—endometrium—ovarian cancer	0.000148	0.0017	CbGeAlD
Metformin—NDUFB4—bone marrow—ovarian cancer	0.000147	0.0017	CbGeAlD
Metformin—NDUFB7—vagina—ovarian cancer	0.000147	0.0017	CbGeAlD
Metformin—NDUFA12—vagina—ovarian cancer	0.000147	0.0017	CbGeAlD
Metformin—NDUFS8—female gonad—ovarian cancer	0.000147	0.0017	CbGeAlD
Metformin—NDUFB1—female gonad—ovarian cancer	0.000147	0.0017	CbGeAlD
Metformin—NDUFAB1—bone marrow—ovarian cancer	0.000146	0.00169	CbGeAlD
Metformin—NDUFB1—vagina—ovarian cancer	0.000146	0.00169	CbGeAlD
Metformin—NDUFS8—vagina—ovarian cancer	0.000146	0.00169	CbGeAlD
Metformin—NDUFA8—bone marrow—ovarian cancer	0.000145	0.00168	CbGeAlD
Metformin—NDUFB9—bone marrow—ovarian cancer	0.000145	0.00168	CbGeAlD
Metformin—PRKAB1—gonad—ovarian cancer	0.000145	0.00168	CbGeAlD
Metformin—NDUFB5—female gonad—ovarian cancer	0.000145	0.00167	CbGeAlD
Metformin—NDUFA6—female gonad—ovarian cancer	0.000145	0.00167	CbGeAlD
Metformin—NDUFA4—bone marrow—ovarian cancer	0.000145	0.00167	CbGeAlD
Metformin—PRKAB1—uterus—ovarian cancer	0.000144	0.00167	CbGeAlD
Metformin—NDUFA10—testis—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFA6—vagina—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFB5—vagina—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFS4—female gonad—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFV1—bone marrow—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFB11—bone marrow—ovarian cancer	0.000144	0.00166	CbGeAlD
Metformin—NDUFS4—vagina—ovarian cancer	0.000143	0.00165	CbGeAlD
Metformin—NDUFB8—bone marrow—ovarian cancer	0.000143	0.00165	CbGeAlD
Metformin—NDUFS5—bone marrow—ovarian cancer	0.000143	0.00165	CbGeAlD
Metformin—NDUFC1—testis—ovarian cancer	0.000143	0.00165	CbGeAlD
Metformin—NDUFB4—female gonad—ovarian cancer	0.000142	0.00164	CbGeAlD
Metformin—NDUFS2—endometrium—ovarian cancer	0.000142	0.00164	CbGeAlD
Metformin—NDUFS7—female reproductive system—ovarian cancer	0.000142	0.00164	CbGeAlD
Metformin—NDUFB2—testis—ovarian cancer	0.000142	0.00164	CbGeAlD
Metformin—NDUFB4—vagina—ovarian cancer	0.000141	0.00163	CbGeAlD
Metformin—NDUFAB1—female gonad—ovarian cancer	0.000141	0.00163	CbGeAlD
Metformin—NDUFAF1—testis—ovarian cancer	0.00014	0.00162	CbGeAlD
Metformin—NDUFAB1—vagina—ovarian cancer	0.00014	0.00162	CbGeAlD
Metformin—NDUFA8—female gonad—ovarian cancer	0.00014	0.00162	CbGeAlD
Metformin—NDUFB9—female gonad—ovarian cancer	0.00014	0.00162	CbGeAlD
Metformin—NDUFS3—endometrium—ovarian cancer	0.00014	0.00162	CbGeAlD
Metformin—NDUFB9—vagina—ovarian cancer	0.000139	0.00161	CbGeAlD
Metformin—NDUFA8—vagina—ovarian cancer	0.000139	0.00161	CbGeAlD
Metformin—NDUFA4—female gonad—ovarian cancer	0.000139	0.00161	CbGeAlD
Metformin—ND6—testis—ovarian cancer	0.000139	0.00161	CbGeAlD
Metformin—NDUFV1—female gonad—ovarian cancer	0.000139	0.0016	CbGeAlD
Metformin—NDUFB11—female gonad—ovarian cancer	0.000139	0.0016	CbGeAlD
Metformin—NDUFA4—vagina—ovarian cancer	0.000139	0.0016	CbGeAlD
Metformin—NDUFB3—testis—ovarian cancer	0.000138	0.0016	CbGeAlD
Metformin—NDUFAF2—testis—ovarian cancer	0.000138	0.0016	CbGeAlD
Metformin—NDUFS5—female gonad—ovarian cancer	0.000138	0.00159	CbGeAlD
Metformin—NDUFB8—female gonad—ovarian cancer	0.000138	0.00159	CbGeAlD
Metformin—NDUFB11—vagina—ovarian cancer	0.000138	0.00159	CbGeAlD
Metformin—NDUFV1—vagina—ovarian cancer	0.000138	0.00159	CbGeAlD
Metformin—NDUFS5—vagina—ovarian cancer	0.000137	0.00158	CbGeAlD
Metformin—NDUFB8—vagina—ovarian cancer	0.000137	0.00158	CbGeAlD
Metformin—NDUFC2—gonad—ovarian cancer	0.000137	0.00158	CbGeAlD
Metformin—NDUFC2—uterus—ovarian cancer	0.000136	0.00157	CbGeAlD
Metformin—NDUFA5—testis—ovarian cancer	0.000135	0.00156	CbGeAlD
Metformin—NDUFA11—testis—ovarian cancer	0.000135	0.00156	CbGeAlD
Metformin—NDUFAF4—testis—ovarian cancer	0.000134	0.00155	CbGeAlD
Metformin—NDUFB6—testis—ovarian cancer	0.000134	0.00155	CbGeAlD
Metformin—NDUFS7—bone marrow—ovarian cancer	0.000134	0.00155	CbGeAlD
Metformin—NDUFS1—testis—ovarian cancer	0.000133	0.00154	CbGeAlD
Metformin—NDUFB10—testis—ovarian cancer	0.000132	0.00153	CbGeAlD
Metformin—NDUFS2—gonad—ovarian cancer	0.000132	0.00152	CbGeAlD
Metformin—NDUFA12—testis—ovarian cancer	0.000131	0.00151	CbGeAlD
Metformin—NDUFB7—testis—ovarian cancer	0.000131	0.00151	CbGeAlD
Metformin—NDUFS2—uterus—ovarian cancer	0.000131	0.00151	CbGeAlD
Metformin—NDUFS8—testis—ovarian cancer	0.00013	0.0015	CbGeAlD
Metformin—NDUFB1—testis—ovarian cancer	0.00013	0.0015	CbGeAlD
Metformin—NDUFS3—gonad—ovarian cancer	0.00013	0.0015	CbGeAlD
Metformin—PRKAB1—female reproductive system—ovarian cancer	0.00013	0.0015	CbGeAlD
Metformin—NDUFS3—uterus—ovarian cancer	0.000129	0.00149	CbGeAlD
Metformin—NDUFS7—female gonad—ovarian cancer	0.000129	0.00149	CbGeAlD
Metformin—NDUFB5—testis—ovarian cancer	0.000128	0.00148	CbGeAlD
Metformin—NDUFA6—testis—ovarian cancer	0.000128	0.00148	CbGeAlD
Metformin—NDUFS7—vagina—ovarian cancer	0.000128	0.00148	CbGeAlD
Metformin—NDUFS4—testis—ovarian cancer	0.000128	0.00147	CbGeAlD
Metformin—NDUFV2—lymph node—ovarian cancer	0.000126	0.00146	CbGeAlD
Metformin—NDUFB4—testis—ovarian cancer	0.000126	0.00146	CbGeAlD
Metformin—NDUFAB1—testis—ovarian cancer	0.000125	0.00145	CbGeAlD
Metformin—NDUFB9—testis—ovarian cancer	0.000124	0.00144	CbGeAlD
Metformin—NDUFA8—testis—ovarian cancer	0.000124	0.00144	CbGeAlD
Metformin—NDUFA4—testis—ovarian cancer	0.000124	0.00143	CbGeAlD
Metformin—NDUFV1—testis—ovarian cancer	0.000123	0.00142	CbGeAlD
Metformin—NDUFB11—testis—ovarian cancer	0.000123	0.00142	CbGeAlD
Metformin—NDUFA4L2—lymph node—ovarian cancer	0.000123	0.00142	CbGeAlD
Metformin—PRKAB1—bone marrow—ovarian cancer	0.000122	0.00141	CbGeAlD
Metformin—NDUFC2—female reproductive system—ovarian cancer	0.000122	0.00141	CbGeAlD
Metformin—NDUFS5—testis—ovarian cancer	0.000122	0.00141	CbGeAlD
Metformin—NDUFB8—testis—ovarian cancer	0.000122	0.00141	CbGeAlD
Metformin—PRKAB1—female gonad—ovarian cancer	0.000118	0.00136	CbGeAlD
Metformin—NDUFS2—female reproductive system—ovarian cancer	0.000118	0.00136	CbGeAlD
Metformin—PRKAB1—vagina—ovarian cancer	0.000117	0.00136	CbGeAlD
Metformin—NDUFS3—female reproductive system—ovarian cancer	0.000116	0.00134	CbGeAlD
Metformin—ND4L—lymph node—ovarian cancer	0.000115	0.00133	CbGeAlD
Metformin—ND3—lymph node—ovarian cancer	0.000115	0.00133	CbGeAlD
Metformin—ND5—lymph node—ovarian cancer	0.000115	0.00133	CbGeAlD
Metformin—ND2—lymph node—ovarian cancer	0.000115	0.00133	CbGeAlD
Metformin—NDUFC2—bone marrow—ovarian cancer	0.000115	0.00133	CbGeAlD
Metformin—NDUFS7—testis—ovarian cancer	0.000114	0.00132	CbGeAlD
Metformin—SLC47A1—myometrium—ovarian cancer	0.000112	0.0013	CbGeAlD
Metformin—ND4—lymph node—ovarian cancer	0.000112	0.00129	CbGeAlD
Metformin—NDUFC2—female gonad—ovarian cancer	0.000111	0.00129	CbGeAlD
Metformin—NDUFS2—bone marrow—ovarian cancer	0.000111	0.00128	CbGeAlD
Metformin—NDUFC2—vagina—ovarian cancer	0.000111	0.00128	CbGeAlD
Metformin—NDUFS3—bone marrow—ovarian cancer	0.00011	0.00127	CbGeAlD
Metformin—NDUFA2—lymph node—ovarian cancer	0.000109	0.00126	CbGeAlD
Metformin—ND1—gonad—ovarian cancer	0.000108	0.00125	CbGeAlD
Metformin—NDUFS2—female gonad—ovarian cancer	0.000107	0.00124	CbGeAlD
Metformin—NDUFS2—vagina—ovarian cancer	0.000106	0.00123	CbGeAlD
Metformin—NDUFS3—female gonad—ovarian cancer	0.000106	0.00122	CbGeAlD
Metformin—NDUFS3—vagina—ovarian cancer	0.000105	0.00121	CbGeAlD
Metformin—PRKAB1—testis—ovarian cancer	0.000105	0.00121	CbGeAlD
Metformin—NDUFA10—lymph node—ovarian cancer	0.000104	0.00121	CbGeAlD
Metformin—NDUFC1—lymph node—ovarian cancer	0.000104	0.0012	CbGeAlD
Metformin—NDUFB2—lymph node—ovarian cancer	0.000103	0.00119	CbGeAlD
Metformin—NDUFAF1—lymph node—ovarian cancer	0.000102	0.00118	CbGeAlD
Metformin—ND6—lymph node—ovarian cancer	0.000101	0.00117	CbGeAlD
Metformin—NDUFAF2—lymph node—ovarian cancer	0.0001	0.00116	CbGeAlD
Metformin—NDUFB3—lymph node—ovarian cancer	0.0001	0.00116	CbGeAlD
Metformin—NDUFC2—testis—ovarian cancer	9.86e-05	0.00114	CbGeAlD
Metformin—NDUFA11—lymph node—ovarian cancer	9.78e-05	0.00113	CbGeAlD
Metformin—NDUFA5—lymph node—ovarian cancer	9.78e-05	0.00113	CbGeAlD
Metformin—NDUFAF4—lymph node—ovarian cancer	9.71e-05	0.00112	CbGeAlD
Metformin—NDUFB6—lymph node—ovarian cancer	9.71e-05	0.00112	CbGeAlD
Metformin—ND1—female reproductive system—ovarian cancer	9.64e-05	0.00111	CbGeAlD
Metformin—NDUFS1—lymph node—ovarian cancer	9.64e-05	0.00111	CbGeAlD
Metformin—NDUFB10—lymph node—ovarian cancer	9.57e-05	0.00111	CbGeAlD
Metformin—NDUFB7—lymph node—ovarian cancer	9.5e-05	0.0011	CbGeAlD
Metformin—NDUFA12—lymph node—ovarian cancer	9.5e-05	0.0011	CbGeAlD
Metformin—NDUFS2—testis—ovarian cancer	9.48e-05	0.0011	CbGeAlD
Metformin—NDUFB1—lymph node—ovarian cancer	9.43e-05	0.00109	CbGeAlD
Metformin—NDUFS8—lymph node—ovarian cancer	9.43e-05	0.00109	CbGeAlD
Metformin—NDUFS3—testis—ovarian cancer	9.37e-05	0.00108	CbGeAlD
Metformin—NDUFB5—lymph node—ovarian cancer	9.31e-05	0.00108	CbGeAlD
Metformin—NDUFA6—lymph node—ovarian cancer	9.31e-05	0.00108	CbGeAlD
Metformin—NDUFS4—lymph node—ovarian cancer	9.25e-05	0.00107	CbGeAlD
Metformin—NDUFB4—lymph node—ovarian cancer	9.13e-05	0.00105	CbGeAlD
Metformin—ND1—bone marrow—ovarian cancer	9.1e-05	0.00105	CbGeAlD
Metformin—NDUFAB1—lymph node—ovarian cancer	9.07e-05	0.00105	CbGeAlD
Metformin—NDUFA8—lymph node—ovarian cancer	9.01e-05	0.00104	CbGeAlD
Metformin—NDUFB9—lymph node—ovarian cancer	9.01e-05	0.00104	CbGeAlD
Metformin—NDUFA4—lymph node—ovarian cancer	8.96e-05	0.00104	CbGeAlD
Metformin—SLC22A3—myometrium—ovarian cancer	8.96e-05	0.00104	CbGeAlD
Metformin—NDUFV1—lymph node—ovarian cancer	8.91e-05	0.00103	CbGeAlD
Metformin—NDUFB11—lymph node—ovarian cancer	8.91e-05	0.00103	CbGeAlD
Metformin—NDUFB8—lymph node—ovarian cancer	8.85e-05	0.00102	CbGeAlD
Metformin—NDUFS5—lymph node—ovarian cancer	8.85e-05	0.00102	CbGeAlD
Metformin—ND1—female gonad—ovarian cancer	8.77e-05	0.00101	CbGeAlD
Metformin—SLC47A1—uterine cervix—ovarian cancer	8.74e-05	0.00101	CbGeAlD
Metformin—SLC22A3—embryo—ovarian cancer	8.62e-05	0.000996	CbGeAlD
Metformin—SLC47A1—decidua—ovarian cancer	8.33e-05	0.000962	CbGeAlD
Metformin—NDUFS7—lymph node—ovarian cancer	8.3e-05	0.000959	CbGeAlD
Metformin—SLC47A1—endometrium—ovarian cancer	7.91e-05	0.000914	CbGeAlD
Metformin—ND1—testis—ovarian cancer	7.78e-05	0.000899	CbGeAlD
Metformin—PRKAB1—lymph node—ovarian cancer	7.59e-05	0.000877	CbGeAlD
Metformin—SLC47A1—gonad—ovarian cancer	7.33e-05	0.000847	CbGeAlD
Metformin—Palpitations—Paclitaxel—ovarian cancer	7.3e-05	0.00146	CcSEcCtD
Metformin—Angiopathy—Docetaxel—ovarian cancer	7.3e-05	0.00146	CcSEcCtD
Metformin—Vomiting—Melphalan—ovarian cancer	7.3e-05	0.00146	CcSEcCtD
Metformin—Dehydration—Epirubicin—ovarian cancer	7.3e-05	0.00146	CcSEcCtD
Metformin—SLC47A1—uterus—ovarian cancer	7.29e-05	0.000842	CbGeAlD
Metformin—Immune system disorder—Docetaxel—ovarian cancer	7.27e-05	0.00145	CcSEcCtD
Metformin—Loss of consciousness—Paclitaxel—ovarian cancer	7.26e-05	0.00145	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—ovarian cancer	7.26e-05	0.00145	CcSEcCtD
Metformin—Mediastinal disorder—Docetaxel—ovarian cancer	7.25e-05	0.00145	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—ovarian cancer	7.24e-05	0.00145	CcSEcCtD
Metformin—Rash—Melphalan—ovarian cancer	7.24e-05	0.00144	CcSEcCtD
Metformin—Dermatitis—Melphalan—ovarian cancer	7.23e-05	0.00144	CcSEcCtD
Metformin—Chills—Docetaxel—ovarian cancer	7.22e-05	0.00144	CcSEcCtD
Metformin—Asthenia—Vinorelbine—ovarian cancer	7.2e-05	0.00144	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—ovarian cancer	7.17e-05	0.00143	CcSEcCtD
Metformin—NDUFC2—lymph node—ovarian cancer	7.15e-05	0.000826	CbGeAlD
Metformin—Migraine—Doxorubicin—ovarian cancer	7.15e-05	0.00143	CcSEcCtD
Metformin—Hypertension—Paclitaxel—ovarian cancer	7.14e-05	0.00142	CcSEcCtD
Metformin—Pruritus—Vinorelbine—ovarian cancer	7.1e-05	0.00142	CcSEcCtD
Metformin—Breast disorder—Epirubicin—ovarian cancer	7.09e-05	0.00141	CcSEcCtD
Metformin—Myalgia—Paclitaxel—ovarian cancer	7.04e-05	0.0014	CcSEcCtD
Metformin—Chest pain—Paclitaxel—ovarian cancer	7.04e-05	0.0014	CcSEcCtD
Metformin—Nasopharyngitis—Epirubicin—ovarian cancer	7.02e-05	0.0014	CcSEcCtD
Metformin—Erythema—Docetaxel—ovarian cancer	7.01e-05	0.0014	CcSEcCtD
Metformin—Malnutrition—Docetaxel—ovarian cancer	7.01e-05	0.0014	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	6.99e-05	0.00139	CcSEcCtD
Metformin—SLC22A3—uterine cervix—ovarian cancer	6.97e-05	0.000805	CbGeAlD
Metformin—Nausea—Topotecan—ovarian cancer	6.96e-05	0.00139	CcSEcCtD
Metformin—Discomfort—Paclitaxel—ovarian cancer	6.95e-05	0.00139	CcSEcCtD
Metformin—NDUFS2—lymph node—ovarian cancer	6.87e-05	0.000794	CbGeAlD
Metformin—Diarrhoea—Vinorelbine—ovarian cancer	6.86e-05	0.00137	CcSEcCtD
Metformin—Dysgeusia—Docetaxel—ovarian cancer	6.86e-05	0.00137	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—ovarian cancer	6.83e-05	0.00136	CcSEcCtD
Metformin—Nausea—Melphalan—ovarian cancer	6.82e-05	0.00136	CcSEcCtD
Metformin—NDUFS3—lymph node—ovarian cancer	6.79e-05	0.000785	CbGeAlD
Metformin—Influenza—Epirubicin—ovarian cancer	6.78e-05	0.00135	CcSEcCtD
Metformin—Dehydration—Doxorubicin—ovarian cancer	6.75e-05	0.00135	CcSEcCtD
Metformin—Oedema—Paclitaxel—ovarian cancer	6.75e-05	0.00135	CcSEcCtD
Metformin—Muscle spasms—Docetaxel—ovarian cancer	6.74e-05	0.00134	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—ovarian cancer	6.7e-05	0.00134	CcSEcCtD
Metformin—Infection—Paclitaxel—ovarian cancer	6.7e-05	0.00134	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—ovarian cancer	6.65e-05	0.00133	CcSEcCtD
Metformin—Shock—Paclitaxel—ovarian cancer	6.64e-05	0.00132	CcSEcCtD
Metformin—Dizziness—Vinorelbine—ovarian cancer	6.63e-05	0.00132	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—ovarian cancer	6.63e-05	0.00132	CcSEcCtD
Metformin—Nervous system disorder—Paclitaxel—ovarian cancer	6.62e-05	0.00132	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—ovarian cancer	6.61e-05	0.00132	CcSEcCtD
Metformin—Thrombocytopenia—Paclitaxel—ovarian cancer	6.61e-05	0.00132	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—ovarian cancer	6.56e-05	0.00131	CcSEcCtD
Metformin—Skin disorder—Paclitaxel—ovarian cancer	6.55e-05	0.00131	CcSEcCtD
Metformin—SLC47A1—female reproductive system—ovarian cancer	6.55e-05	0.000757	CbGeAlD
Metformin—Hyperhidrosis—Paclitaxel—ovarian cancer	6.52e-05	0.0013	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—ovarian cancer	6.49e-05	0.0013	CcSEcCtD
Metformin—Anorexia—Paclitaxel—ovarian cancer	6.43e-05	0.00128	CcSEcCtD
Metformin—Vomiting—Vinorelbine—ovarian cancer	6.38e-05	0.00127	CcSEcCtD
Metformin—Neutropenia—Epirubicin—ovarian cancer	6.34e-05	0.00127	CcSEcCtD
Metformin—Rash—Vinorelbine—ovarian cancer	6.32e-05	0.00126	CcSEcCtD
Metformin—Dermatitis—Vinorelbine—ovarian cancer	6.32e-05	0.00126	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—ovarian cancer	6.32e-05	0.00126	CcSEcCtD
Metformin—SLC22A3—endometrium—ovarian cancer	6.3e-05	0.000729	CbGeAlD
Metformin—Hypotension—Paclitaxel—ovarian cancer	6.3e-05	0.00126	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—ovarian cancer	6.3e-05	0.00126	CcSEcCtD
Metformin—Headache—Vinorelbine—ovarian cancer	6.28e-05	0.00125	CcSEcCtD
Metformin—Syncope—Docetaxel—ovarian cancer	6.28e-05	0.00125	CcSEcCtD
Metformin—Influenza—Doxorubicin—ovarian cancer	6.28e-05	0.00125	CcSEcCtD
Metformin—Palpitations—Docetaxel—ovarian cancer	6.19e-05	0.00124	CcSEcCtD
Metformin—Loss of consciousness—Docetaxel—ovarian cancer	6.16e-05	0.00123	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—ovarian cancer	6.15e-05	0.00123	CcSEcCtD
Metformin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	6.15e-05	0.00123	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—ovarian cancer	6.11e-05	0.00122	CcSEcCtD
Metformin—Paraesthesia—Paclitaxel—ovarian cancer	6.06e-05	0.00121	CcSEcCtD
Metformin—Hypertension—Docetaxel—ovarian cancer	6.05e-05	0.00121	CcSEcCtD
Metformin—Infestation—Epirubicin—ovarian cancer	6.05e-05	0.00121	CcSEcCtD
Metformin—Drowsiness—Epirubicin—ovarian cancer	6.05e-05	0.00121	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—ovarian cancer	6.05e-05	0.00121	CcSEcCtD
Metformin—Dyspnoea—Paclitaxel—ovarian cancer	6.01e-05	0.0012	CcSEcCtD
Metformin—Somnolence—Paclitaxel—ovarian cancer	6e-05	0.0012	CcSEcCtD
Metformin—Myalgia—Docetaxel—ovarian cancer	5.96e-05	0.00119	CcSEcCtD
Metformin—Chest pain—Docetaxel—ovarian cancer	5.96e-05	0.00119	CcSEcCtD
Metformin—SLC47A1—female gonad—ovarian cancer	5.96e-05	0.000689	CbGeAlD
Metformin—Nausea—Vinorelbine—ovarian cancer	5.96e-05	0.00119	CcSEcCtD
Metformin—Dyspepsia—Paclitaxel—ovarian cancer	5.94e-05	0.00118	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—ovarian cancer	5.93e-05	0.00118	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	5.92e-05	0.00118	CcSEcCtD
Metformin—SLC47A1—vagina—ovarian cancer	5.92e-05	0.000684	CbGeAlD
Metformin—Neutropenia—Doxorubicin—ovarian cancer	5.87e-05	0.00117	CcSEcCtD
Metformin—Decreased appetite—Paclitaxel—ovarian cancer	5.86e-05	0.00117	CcSEcCtD
Metformin—SLC22A3—gonad—ovarian cancer	5.85e-05	0.000676	CbGeAlD
Metformin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	5.83e-05	0.00116	CcSEcCtD
Metformin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	5.82e-05	0.00116	CcSEcCtD
Metformin—Fatigue—Paclitaxel—ovarian cancer	5.82e-05	0.00116	CcSEcCtD
Metformin—Constipation—Paclitaxel—ovarian cancer	5.77e-05	0.00115	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—ovarian cancer	5.72e-05	0.00114	CcSEcCtD
Metformin—Oedema—Docetaxel—ovarian cancer	5.72e-05	0.00114	CcSEcCtD
Metformin—Infection—Docetaxel—ovarian cancer	5.68e-05	0.00113	CcSEcCtD
Metformin—ND1—lymph node—ovarian cancer	5.64e-05	0.000652	CbGeAlD
Metformin—Shock—Docetaxel—ovarian cancer	5.63e-05	0.00112	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—ovarian cancer	5.61e-05	0.00112	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—ovarian cancer	5.6e-05	0.00112	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—ovarian cancer	5.6e-05	0.00112	CcSEcCtD
Metformin—Infestation—Doxorubicin—ovarian cancer	5.6e-05	0.00112	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—ovarian cancer	5.6e-05	0.00112	CcSEcCtD
Metformin—Feeling abnormal—Paclitaxel—ovarian cancer	5.56e-05	0.00111	CcSEcCtD
Metformin—Skin disorder—Docetaxel—ovarian cancer	5.55e-05	0.00111	CcSEcCtD
Metformin—Bradycardia—Epirubicin—ovarian cancer	5.53e-05	0.0011	CcSEcCtD
Metformin—Gastrointestinal pain—Paclitaxel—ovarian cancer	5.52e-05	0.0011	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—ovarian cancer	5.48e-05	0.00109	CcSEcCtD
Metformin—Anorexia—Docetaxel—ovarian cancer	5.45e-05	0.00109	CcSEcCtD
Metformin—Rhinitis—Epirubicin—ovarian cancer	5.44e-05	0.00109	CcSEcCtD
Metformin—Hepatitis—Epirubicin—ovarian cancer	5.43e-05	0.00108	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—ovarian cancer	5.4e-05	0.00108	CcSEcCtD
Metformin—Urticaria—Paclitaxel—ovarian cancer	5.36e-05	0.00107	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—ovarian cancer	5.35e-05	0.00107	CcSEcCtD
Metformin—Hypotension—Docetaxel—ovarian cancer	5.34e-05	0.00107	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—ovarian cancer	5.33e-05	0.00106	CcSEcCtD
Metformin—Abdominal pain—Paclitaxel—ovarian cancer	5.33e-05	0.00106	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—ovarian cancer	5.29e-05	0.00106	CcSEcCtD
Metformin—SLC47A1—testis—ovarian cancer	5.29e-05	0.000611	CbGeAlD
Metformin—SLC22A3—female reproductive system—ovarian cancer	5.22e-05	0.000603	CbGeAlD
Metformin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	5.21e-05	0.00104	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—ovarian cancer	5.13e-05	0.00102	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—ovarian cancer	5.11e-05	0.00102	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—ovarian cancer	5.1e-05	0.00102	CcSEcCtD
Metformin—Somnolence—Docetaxel—ovarian cancer	5.08e-05	0.00101	CcSEcCtD
Metformin—Eye disorder—Epirubicin—ovarian cancer	5.07e-05	0.00101	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—ovarian cancer	5.04e-05	0.00101	CcSEcCtD
Metformin—Flushing—Epirubicin—ovarian cancer	5.04e-05	0.00101	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—ovarian cancer	5.04e-05	0.001	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—ovarian cancer	5.03e-05	0.001	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—ovarian cancer	5.02e-05	0.001	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—ovarian cancer	5e-05	0.000997	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—ovarian cancer	4.97e-05	0.000992	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—ovarian cancer	4.95e-05	0.000987	CcSEcCtD
Metformin—SLC22A1—vagina—ovarian cancer	4.94e-05	0.000571	CbGeAlD
Metformin—Gastrointestinal disorder—Docetaxel—ovarian cancer	4.94e-05	0.000985	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—ovarian cancer	4.94e-05	0.000985	CcSEcCtD
Metformin—Fatigue—Docetaxel—ovarian cancer	4.93e-05	0.000983	CcSEcCtD
Metformin—Angiopathy—Epirubicin—ovarian cancer	4.93e-05	0.000982	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—ovarian cancer	4.9e-05	0.000978	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—ovarian cancer	4.89e-05	0.000976	CcSEcCtD
Metformin—Constipation—Docetaxel—ovarian cancer	4.89e-05	0.000975	CcSEcCtD
Metformin—Chills—Epirubicin—ovarian cancer	4.87e-05	0.000972	CcSEcCtD
Metformin—Asthenia—Paclitaxel—ovarian cancer	4.84e-05	0.000966	CcSEcCtD
Metformin—Pruritus—Paclitaxel—ovarian cancer	4.77e-05	0.000952	CcSEcCtD
Metformin—SLC22A3—female gonad—ovarian cancer	4.75e-05	0.000549	CbGeAlD
Metformin—Erythema—Epirubicin—ovarian cancer	4.73e-05	0.000943	CcSEcCtD
Metformin—Malnutrition—Epirubicin—ovarian cancer	4.73e-05	0.000943	CcSEcCtD
Metformin—SLC22A3—vagina—ovarian cancer	4.72e-05	0.000546	CbGeAlD
Metformin—Feeling abnormal—Docetaxel—ovarian cancer	4.71e-05	0.00094	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—ovarian cancer	4.69e-05	0.000936	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—ovarian cancer	4.68e-05	0.000933	CcSEcCtD
Metformin—Flushing—Doxorubicin—ovarian cancer	4.66e-05	0.00093	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—ovarian cancer	4.66e-05	0.00093	CcSEcCtD
Metformin—Flatulence—Epirubicin—ovarian cancer	4.66e-05	0.000929	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—ovarian cancer	4.63e-05	0.000923	CcSEcCtD
Metformin—Diarrhoea—Paclitaxel—ovarian cancer	4.62e-05	0.000921	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—ovarian cancer	4.56e-05	0.000909	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—ovarian cancer	4.54e-05	0.000906	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—ovarian cancer	4.54e-05	0.000905	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—ovarian cancer	4.53e-05	0.000903	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—ovarian cancer	4.52e-05	0.000902	CcSEcCtD
Metformin—Chills—Doxorubicin—ovarian cancer	4.51e-05	0.000899	CcSEcCtD
Metformin—Dizziness—Paclitaxel—ovarian cancer	4.46e-05	0.00089	CcSEcCtD
Metformin—Vision blurred—Epirubicin—ovarian cancer	4.45e-05	0.000888	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—ovarian cancer	4.38e-05	0.000875	CcSEcCtD
Metformin—Erythema—Doxorubicin—ovarian cancer	4.37e-05	0.000872	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—ovarian cancer	4.37e-05	0.000872	CcSEcCtD
Metformin—Flatulence—Doxorubicin—ovarian cancer	4.31e-05	0.000859	CcSEcCtD
Metformin—Vomiting—Paclitaxel—ovarian cancer	4.29e-05	0.000856	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—ovarian cancer	4.28e-05	0.000854	CcSEcCtD
Metformin—Malaise—Epirubicin—ovarian cancer	4.26e-05	0.00085	CcSEcCtD
Metformin—Rash—Paclitaxel—ovarian cancer	4.25e-05	0.000848	CcSEcCtD
Metformin—Dermatitis—Paclitaxel—ovarian cancer	4.25e-05	0.000848	CcSEcCtD
Metformin—Syncope—Epirubicin—ovarian cancer	4.24e-05	0.000845	CcSEcCtD
Metformin—Headache—Paclitaxel—ovarian cancer	4.23e-05	0.000843	CcSEcCtD
Metformin—SLC22A3—testis—ovarian cancer	4.21e-05	0.000487	CbGeAlD
Metformin—Muscle spasms—Doxorubicin—ovarian cancer	4.2e-05	0.000839	CcSEcCtD
Metformin—Palpitations—Epirubicin—ovarian cancer	4.18e-05	0.000833	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—ovarian cancer	4.15e-05	0.000829	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—ovarian cancer	4.12e-05	0.000822	CcSEcCtD
Metformin—Asthenia—Docetaxel—ovarian cancer	4.1e-05	0.000818	CcSEcCtD
Metformin—Hypertension—Epirubicin—ovarian cancer	4.08e-05	0.000814	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—ovarian cancer	4.06e-05	0.000809	CcSEcCtD
Metformin—Pruritus—Docetaxel—ovarian cancer	4.05e-05	0.000807	CcSEcCtD
Metformin—Chest pain—Epirubicin—ovarian cancer	4.02e-05	0.000803	CcSEcCtD
Metformin—Myalgia—Epirubicin—ovarian cancer	4.02e-05	0.000803	CcSEcCtD
Metformin—Nausea—Paclitaxel—ovarian cancer	4.01e-05	0.000799	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4e-05	0.000797	CcSEcCtD
Metformin—Discomfort—Epirubicin—ovarian cancer	3.97e-05	0.000793	CcSEcCtD
Metformin—Malaise—Doxorubicin—ovarian cancer	3.94e-05	0.000787	CcSEcCtD
Metformin—Syncope—Doxorubicin—ovarian cancer	3.92e-05	0.000782	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—ovarian cancer	3.91e-05	0.00078	CcSEcCtD
Metformin—Palpitations—Doxorubicin—ovarian cancer	3.86e-05	0.000771	CcSEcCtD
Metformin—Oedema—Epirubicin—ovarian cancer	3.86e-05	0.000769	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—ovarian cancer	3.84e-05	0.000767	CcSEcCtD
Metformin—Infection—Epirubicin—ovarian cancer	3.83e-05	0.000764	CcSEcCtD
Metformin—SLC47A1—lymph node—ovarian cancer	3.83e-05	0.000443	CbGeAlD
Metformin—Shock—Epirubicin—ovarian cancer	3.79e-05	0.000757	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—ovarian cancer	3.78e-05	0.000754	CcSEcCtD
Metformin—Dizziness—Docetaxel—ovarian cancer	3.78e-05	0.000754	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—ovarian cancer	3.78e-05	0.000753	CcSEcCtD
Metformin—Hypertension—Doxorubicin—ovarian cancer	3.78e-05	0.000753	CcSEcCtD
Metformin—Skin disorder—Epirubicin—ovarian cancer	3.75e-05	0.000747	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—ovarian cancer	3.73e-05	0.000744	CcSEcCtD
Metformin—Myalgia—Doxorubicin—ovarian cancer	3.72e-05	0.000743	CcSEcCtD
Metformin—Chest pain—Doxorubicin—ovarian cancer	3.72e-05	0.000743	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	3.7e-05	0.000737	CcSEcCtD
Metformin—Discomfort—Doxorubicin—ovarian cancer	3.68e-05	0.000734	CcSEcCtD
Metformin—Anorexia—Epirubicin—ovarian cancer	3.68e-05	0.000733	CcSEcCtD
Metformin—Vomiting—Docetaxel—ovarian cancer	3.64e-05	0.000725	CcSEcCtD
Metformin—Rash—Docetaxel—ovarian cancer	3.61e-05	0.000719	CcSEcCtD
Metformin—Hypotension—Epirubicin—ovarian cancer	3.6e-05	0.000719	CcSEcCtD
Metformin—Dermatitis—Docetaxel—ovarian cancer	3.6e-05	0.000719	CcSEcCtD
Metformin—Headache—Docetaxel—ovarian cancer	3.58e-05	0.000715	CcSEcCtD
Metformin—Oedema—Doxorubicin—ovarian cancer	3.57e-05	0.000712	CcSEcCtD
Metformin—Infection—Doxorubicin—ovarian cancer	3.55e-05	0.000707	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	3.51e-05	0.000701	CcSEcCtD
Metformin—Shock—Doxorubicin—ovarian cancer	3.51e-05	0.0007	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—ovarian cancer	3.5e-05	0.000698	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—ovarian cancer	3.49e-05	0.000697	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—ovarian cancer	3.47e-05	0.000691	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—ovarian cancer	3.46e-05	0.000691	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—ovarian cancer	3.45e-05	0.000688	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—ovarian cancer	3.44e-05	0.000686	CcSEcCtD
Metformin—Somnolence—Epirubicin—ovarian cancer	3.43e-05	0.000684	CcSEcCtD
Metformin—Anorexia—Doxorubicin—ovarian cancer	3.4e-05	0.000679	CcSEcCtD
Metformin—Nausea—Docetaxel—ovarian cancer	3.4e-05	0.000678	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—ovarian cancer	3.39e-05	0.000677	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—ovarian cancer	3.35e-05	0.000669	CcSEcCtD
Metformin—Hypotension—Doxorubicin—ovarian cancer	3.33e-05	0.000665	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.33e-05	0.000664	CcSEcCtD
Metformin—Fatigue—Epirubicin—ovarian cancer	3.33e-05	0.000663	CcSEcCtD
Metformin—Constipation—Epirubicin—ovarian cancer	3.3e-05	0.000658	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.25e-05	0.000649	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—ovarian cancer	3.2e-05	0.000639	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—ovarian cancer	3.18e-05	0.000635	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—ovarian cancer	3.18e-05	0.000634	CcSEcCtD
Metformin—Somnolence—Doxorubicin—ovarian cancer	3.17e-05	0.000633	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—ovarian cancer	3.15e-05	0.000629	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—ovarian cancer	3.14e-05	0.000627	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—ovarian cancer	3.1e-05	0.000619	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.08e-05	0.000615	CcSEcCtD
Metformin—Fatigue—Doxorubicin—ovarian cancer	3.08e-05	0.000614	CcSEcCtD
Metformin—Urticaria—Epirubicin—ovarian cancer	3.06e-05	0.000611	CcSEcCtD
Metformin—SLC22A3—lymph node—ovarian cancer	3.06e-05	0.000353	CbGeAlD
Metformin—Constipation—Doxorubicin—ovarian cancer	3.05e-05	0.000609	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—ovarian cancer	3.05e-05	0.000608	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—ovarian cancer	2.94e-05	0.000587	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—ovarian cancer	2.92e-05	0.000582	CcSEcCtD
Metformin—Urticaria—Doxorubicin—ovarian cancer	2.83e-05	0.000566	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—ovarian cancer	2.82e-05	0.000563	CcSEcCtD
Metformin—Asthenia—Epirubicin—ovarian cancer	2.77e-05	0.000552	CcSEcCtD
Metformin—Pruritus—Epirubicin—ovarian cancer	2.73e-05	0.000544	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—ovarian cancer	2.64e-05	0.000526	CcSEcCtD
Metformin—Asthenia—Doxorubicin—ovarian cancer	2.56e-05	0.000511	CcSEcCtD
Metformin—Dizziness—Epirubicin—ovarian cancer	2.55e-05	0.000509	CcSEcCtD
Metformin—Pruritus—Doxorubicin—ovarian cancer	2.52e-05	0.000504	CcSEcCtD
Metformin—Vomiting—Epirubicin—ovarian cancer	2.45e-05	0.000489	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—ovarian cancer	2.44e-05	0.000487	CcSEcCtD
Metformin—Rash—Epirubicin—ovarian cancer	2.43e-05	0.000485	CcSEcCtD
Metformin—Dermatitis—Epirubicin—ovarian cancer	2.43e-05	0.000485	CcSEcCtD
Metformin—Headache—Epirubicin—ovarian cancer	2.42e-05	0.000482	CcSEcCtD
Metformin—Dizziness—Doxorubicin—ovarian cancer	2.36e-05	0.000471	CcSEcCtD
Metformin—Nausea—Epirubicin—ovarian cancer	2.29e-05	0.000457	CcSEcCtD
Metformin—Vomiting—Doxorubicin—ovarian cancer	2.27e-05	0.000453	CcSEcCtD
Metformin—Rash—Doxorubicin—ovarian cancer	2.25e-05	0.000449	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—ovarian cancer	2.25e-05	0.000448	CcSEcCtD
Metformin—Headache—Doxorubicin—ovarian cancer	2.24e-05	0.000446	CcSEcCtD
Metformin—Nausea—Doxorubicin—ovarian cancer	2.12e-05	0.000423	CcSEcCtD
Metformin—ND1—Metabolism—PPP2R1A—ovarian cancer	6.62e-06	8.4e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CG—ovarian cancer	6.47e-06	8.2e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTEN—ovarian cancer	6.46e-06	8.2e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTEN—ovarian cancer	6.46e-06	8.2e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTEN—ovarian cancer	6.46e-06	8.2e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTEN—ovarian cancer	6.46e-06	8.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PARP1—ovarian cancer	6.3e-06	7.99e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CB—ovarian cancer	6.2e-06	7.86e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ABCB1—ovarian cancer	6.15e-06	7.8e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.12e-06	7.76e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CD—ovarian cancer	6.05e-06	7.67e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CD—ovarian cancer	6.05e-06	7.67e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CD—ovarian cancer	6.05e-06	7.67e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—TYMS—ovarian cancer	6.04e-06	7.66e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—ovarian cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CD—ovarian cancer	5.69e-06	7.21e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—ovarian cancer	5.36e-06	6.79e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CB—ovarian cancer	5.27e-06	6.68e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CB—ovarian cancer	5.27e-06	6.68e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CB—ovarian cancer	5.27e-06	6.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PPP2R1A—ovarian cancer	5.11e-06	6.48e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.03e-06	6.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYTB—ovarian cancer	5.01e-06	6.36e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—ovarian cancer	4.99e-06	6.32e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CB—ovarian cancer	4.96e-06	6.28e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CAV1—ovarian cancer	4.87e-06	6.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.86e-06	6.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.69e-06	5.95e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—YAP1—ovarian cancer	4.69e-06	5.94e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYTB—ovarian cancer	4.67e-06	5.92e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—ovarian cancer	4.56e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—ovarian cancer	4.56e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—ovarian cancer	4.56e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—ovarian cancer	4.56e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—ovarian cancer	4.55e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—ovarian cancer	4.55e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—ovarian cancer	4.55e-06	5.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.53e-06	5.74e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—ovarian cancer	4.43e-06	5.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BRIP1—ovarian cancer	4.38e-06	5.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPP1CC—ovarian cancer	4.38e-06	5.56e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—ovarian cancer	4.28e-06	5.43e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—ovarian cancer	4.24e-06	5.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BRIP1—ovarian cancer	4.08e-06	5.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPP1CC—ovarian cancer	4.08e-06	5.18e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—ovarian cancer	4.07e-06	5.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—ovarian cancer	4.06e-06	5.15e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—ovarian cancer	3.9e-06	4.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.84e-06	4.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—FASN—ovarian cancer	3.82e-06	4.84e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—ovarian cancer	3.78e-06	4.79e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—ovarian cancer	3.76e-06	4.76e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CAV1—ovarian cancer	3.76e-06	4.76e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—ovarian cancer	3.73e-06	4.72e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—ovarian cancer	3.73e-06	4.72e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—ovarian cancer	3.73e-06	4.72e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—ovarian cancer	3.73e-06	4.72e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A1—ovarian cancer	3.63e-06	4.6e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—ovarian cancer	3.62e-06	4.59e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.61e-06	4.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.58e-06	4.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6ST—ovarian cancer	3.56e-06	4.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1B1—ovarian cancer	3.48e-06	4.41e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—ovarian cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—ovarian cancer	3.42e-06	4.34e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—ovarian cancer	3.42e-06	4.34e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—ovarian cancer	3.4e-06	4.31e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.37e-06	4.27e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—ovarian cancer	3.21e-06	4.07e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—ovarian cancer	3.21e-06	4.07e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—ovarian cancer	3.21e-06	4.07e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—ovarian cancer	3.09e-06	3.91e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPP2R1A—ovarian cancer	3.09e-06	3.91e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—ovarian cancer	3.02e-06	3.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—ovarian cancer	3.01e-06	3.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—YAP1—ovarian cancer	2.94e-06	3.73e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—ovarian cancer	2.93e-06	3.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.9e-06	3.68e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—ovarian cancer	2.86e-06	3.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—ovarian cancer	2.81e-06	3.57e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MAPK1—ovarian cancer	2.77e-06	3.51e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—YAP1—ovarian cancer	2.74e-06	3.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.7e-06	3.43e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—ovarian cancer	2.66e-06	3.37e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—ovarian cancer	2.62e-06	3.33e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—ovarian cancer	2.62e-06	3.33e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—ovarian cancer	2.62e-06	3.33e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—ovarian cancer	2.62e-06	3.32e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—ovarian cancer	2.62e-06	3.32e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MAPK1—ovarian cancer	2.58e-06	3.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—ovarian cancer	2.52e-06	3.19e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—ovarian cancer	2.47e-06	3.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—ovarian cancer	2.46e-06	3.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—ovarian cancer	2.41e-06	3.06e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—ovarian cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FASN—ovarian cancer	2.4e-06	3.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—ovarian cancer	2.36e-06	2.99e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—ovarian cancer	2.35e-06	2.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—ovarian cancer	2.32e-06	2.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—ovarian cancer	2.28e-06	2.89e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A1—ovarian cancer	2.28e-06	2.89e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAV1—ovarian cancer	2.27e-06	2.87e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—ovarian cancer	2.26e-06	2.87e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FASN—ovarian cancer	2.23e-06	2.83e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—ovarian cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—ovarian cancer	2.2e-06	2.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1B1—ovarian cancer	2.18e-06	2.77e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A1—ovarian cancer	2.12e-06	2.69e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—ovarian cancer	2.07e-06	2.63e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—ovarian cancer	2.07e-06	2.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—ovarian cancer	2.07e-06	2.62e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—ovarian cancer	2.05e-06	2.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1B1—ovarian cancer	2.03e-06	2.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—ovarian cancer	2.03e-06	2.57e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—ovarian cancer	2.02e-06	2.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—ovarian cancer	1.94e-06	2.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.94e-06	2.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—ovarian cancer	1.88e-06	2.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK1—ovarian cancer	1.84e-06	2.33e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—ovarian cancer	1.84e-06	2.33e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—ovarian cancer	1.82e-06	2.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.8e-06	2.29e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.8e-06	2.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—ovarian cancer	1.76e-06	2.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—ovarian cancer	1.74e-06	2.21e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—ovarian cancer	1.69e-06	2.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.67e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—ovarian cancer	1.64e-06	2.09e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—ovarian cancer	1.6e-06	2.03e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—ovarian cancer	1.58e-06	2.01e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—ovarian cancer	1.55e-06	1.96e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—ovarian cancer	1.48e-06	1.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAV1—ovarian cancer	1.42e-06	1.8e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—ovarian cancer	1.41e-06	1.79e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—ovarian cancer	1.37e-06	1.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAV1—ovarian cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—ovarian cancer	1.31e-06	1.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—ovarian cancer	1.3e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—ovarian cancer	1.21e-06	1.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—ovarian cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—ovarian cancer	1.06e-06	1.35e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—ovarian cancer	9.92e-07	1.26e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—ovarian cancer	9.65e-07	1.22e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—ovarian cancer	9.25e-07	1.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—ovarian cancer	8.58e-07	1.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—ovarian cancer	7.99e-07	1.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—ovarian cancer	7.88e-07	9.99e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—ovarian cancer	6.05e-07	7.67e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—ovarian cancer	5.64e-07	7.15e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—ovarian cancer	4.94e-07	6.27e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—ovarian cancer	4.61e-07	5.84e-06	CbGpPWpGaD
